Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/15/2012 | WO2012155057A2 Planar probe and system for measuring dielectric properties of biological materials |
11/15/2012 | WO2012155039A1 Diagnosis and treatment of copd |
11/15/2012 | WO2012155019A1 Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature pepides |
11/15/2012 | WO2012154987A1 Methods of disease activity profiling for personalized therapy management |
11/15/2012 | WO2012154983A2 Systems and methods for anti-pax8 antibodies |
11/15/2012 | WO2012154957A2 Diagnosis and prognosis of triple negative breast and ovarian cancer |
11/15/2012 | WO2012154933A1 Detecting inclusion body myositis |
11/15/2012 | WO2012154889A1 Serum s100b and uses thereof |
11/15/2012 | WO2012154858A1 Chaperone interaction assays and uses thereof |
11/15/2012 | WO2012154794A2 Enzyme concentration and assays |
11/15/2012 | WO2012154745A2 Microfluidic feedback using impedance detection |
11/15/2012 | WO2012154729A1 A microfluidic module and uses thereof |
11/15/2012 | WO2012154726A1 Method of enhanced detection for nanomaterial-based molecular sensors |
11/15/2012 | WO2012154722A1 Predictive biomarkers for prostate cancer |
11/15/2012 | WO2012154705A1 Methods for diagnosing degenerative joint disease |
11/15/2012 | WO2012154688A2 Methods and devices to control fluid volumes, reagent and particle concentration in arrays of microfluidic drops |
11/15/2012 | WO2012154672A2 Point-of-care, medical condition screening kit |
11/15/2012 | WO2012154555A1 Nanocompositions for monitoring polymerase chain reaction (pcr) |
11/15/2012 | WO2012154511A2 Method and device for statistical tissue sampling using microdevices |
11/15/2012 | WO2012154484A1 Compositions and methods for antibody and ligand identification |
11/15/2012 | WO2012154312A1 Neutralizing antibodies to hiv-1 and their use |
11/15/2012 | WO2012154306A1 Bio-nano-chips for on-site drug screening |
11/15/2012 | WO2012154272A1 Assays for detecting enzymatic activity |
11/15/2012 | WO2012154263A1 Method of identifying compounds that specifically modulate the interaction of fgfr1 and beta-klotho |
11/15/2012 | WO2012154257A1 Apparatus and method for isolating leukocytes and tumor cells by filtration |
11/15/2012 | WO2012154253A1 ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS |
11/15/2012 | WO2012153964A2 Method for providing information for the histological classification of non-small-cell lung carcinoma using lipid profiles |
11/15/2012 | WO2012153854A1 Cytokine-chemokine modulator |
11/15/2012 | WO2012153773A1 Method for immunologically measuring soluble lr11 |
11/15/2012 | WO2012153723A1 Microchip liquid feeding system |
11/15/2012 | WO2012153492A1 Nptx2 as tumor marker and therapeutic target for cancer |
11/15/2012 | WO2012153326A1 Diagnosis of cancer |
11/15/2012 | WO2012153196A2 Glu-glp-1 dual agonist signaling-selective compounds |
11/15/2012 | WO2012153187A2 Markers for cancer prognosis and therapy and methods of use |
11/15/2012 | WO2012153127A1 Screening for anxiolytic drugs by testing drosophila in an open-field test |
11/15/2012 | WO2012153124A1 Electrochemical sensor for the detection of one or more biomarkers tuberculosis in breath |
11/15/2012 | WO2012153111A1 Method for determining the presence or absence of a biomarker |
11/15/2012 | WO2012153078A1 Method of in vitro determination of the presence of multiple sclerosis of primatively progressive form |
11/15/2012 | WO2012153031A1 Method for the detection and early serotyping of the dengue virus |
11/15/2012 | WO2012152970A1 Method for the diagnosis of ischemic stroke |
11/15/2012 | WO2012152941A1 Method for determining intrinsic binding parameters of an analyte to a ligand, a method for selecting an analyte from a group of analyts, the selected ligand or analyte, and sensor |
11/15/2012 | WO2012152935A1 Method and apparatus for analyzing alkalinity conditions in aqueous liquids |
11/15/2012 | WO2012152747A2 Spectral imaging for measurement of nuclear pathology features in cancer cells prepared for in situ analysis |
11/15/2012 | WO2012152716A1 Biochemical markers for cvd risk assessment |
11/15/2012 | WO2012152222A1 Bifunctional tumour diagnosis reagent and method therefor |
11/15/2012 | WO2012151736A1 Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma |
11/15/2012 | WO2012151704A1 Glycosaminoglycan-based therapy for the prevention/treatment of systemic sclerosis |
11/15/2012 | WO2012151702A1 Monoclonal antibody for acetylamantadine |
11/15/2012 | WO2012151673A1 Use of algae in recovery |
11/15/2012 | WO2012151672A1 Method of predicting risk of neonatal lupus erythematosus |
11/15/2012 | WO2012127124A9 Tests dedicated to oncology and to neuro-oncology |
11/15/2012 | WO2012122379A3 Microfluidic cytochemical staining system |
11/15/2012 | WO2012122128A3 Detection of cancer by volatile organic compounds from breath |
11/15/2012 | WO2012120038A3 A polypeptide comprising n-terminal fragment of a cystatin for use in diagnosing and/or treating sterility |
11/15/2012 | WO2012117244A3 Apparatus for testing the quality of a fluid sample |
11/15/2012 | WO2012109383A3 Method of determining protein binding characteristics of a drug candidate |
11/15/2012 | WO2012107567A3 Detection and removal of misfolded proteins/peptides |
11/15/2012 | WO2012100361A3 Method for manufacturing a sensor chip comprising a device for testing it |
11/15/2012 | WO2012097084A3 Tenomodulin (tnmd) isoforms and uses thereof |
11/15/2012 | WO2012097081A3 Protein detection method |
11/15/2012 | WO2012096953A3 Electrical imager operating in oil-based mud and low resistive formation |
11/15/2012 | WO2012088351A3 Compact wide-field fluorescent imaging on a mobile device |
11/15/2012 | WO2012069993A3 Carbon nanotube sensor |
11/15/2012 | WO2012017343A3 Cardiomyocyte containing device, manufacturing method and measuring method |
11/15/2012 | US20120291145 Transgenic mice over-expressing receptor for advanced glycation endproduct (rage) in brain and uses thereof |
11/15/2012 | US20120290261 Valve actuator fault analysis system |
11/15/2012 | US20120289863 Diagnostic device and method for sensing hydration state of a mammalian subject |
11/15/2012 | US20120289679 Novel mite allergen |
11/15/2012 | US20120289558 Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
11/15/2012 | US20120289479 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and Cholesterol |
11/15/2012 | US20120289459 Antiviral peptides from african swine fever virus which prevent the binding of the virus to dlc8 |
11/15/2012 | US20120289458 Treatment of influenza virus infection |
11/15/2012 | US20120289433 Solid surface reservoirs |
11/15/2012 | US20120289431 Diagnosis of breast cancer based on expression level of thioredoxin-1 |
11/15/2012 | US20120289418 Diagnostic method and kit for the detection of a lymphocytic variant of hypereosinophilic syndrome |
11/15/2012 | US20120289417 T Cell Epitope Databases |
11/15/2012 | US20120289416 Methods and kits used in assessing cancer risk |
11/15/2012 | US20120288961 Capillarity-based devices for performing chemical processes and associated systems and methods |
11/15/2012 | US20120288959 Rapid detection of cerebrospinal fluid, methods and systems therefore |
11/15/2012 | US20120288951 Detection of vapor phase compounds by changes in physical properties of a liquid crystal |
11/15/2012 | US20120288945 System and method for determining contaminants in wastewater including shipboard bilge water |
11/15/2012 | US20120288924 Cartridge for conducting a chemical reaction |
11/15/2012 | US20120288923 Instrument and Method for Automatically Heat-Sealing a Microplate |
11/15/2012 | US20120288886 Inhibiting binding of fgf23 to the binary fgfr-klotho complex for the treatment of hypophosphatemia |
11/15/2012 | US20120288882 Type iv secretion system proteins in sero-detection of anaplasma phagocytophilum |
11/15/2012 | US20120288881 Method for Evaluating the Cure Level of Stroke |
11/15/2012 | US20120288880 Methods and compositions for diagnosis or prognosis of cardiovascular disease |
11/15/2012 | US20120288879 Methods for developing and assessing therapeutic agents |
11/15/2012 | US20120288878 Methods for identifying immunobinders of cell-surface antigens |
11/15/2012 | US20120288876 Novel identified oncogene with kinase-domain (nok) |
11/15/2012 | US20120288875 Diagnostic Test For The Detection Of A Molecule Or Drug In Whole Blood |
11/15/2012 | US20120288874 Enzymatic activity-based detection |
11/15/2012 | US20120288873 Biomarkers for the detection and screening of down syndrome |
11/15/2012 | US20120288872 Gene defects and mutant alk kinase in human solid tumors |
11/15/2012 | US20120288871 Modified Carbocyanine Dyes and Their Conjugates |
11/15/2012 | US20120288868 Isolation of nucleic acids |
11/15/2012 | US20120288856 Molecular sexing of avian subjects |
11/15/2012 | US20120288851 Measurement System, Measurement Method, Program for Implementing the Method, and Recording Medium for the Program |
11/15/2012 | US20120288849 Method and system for robust and sensitive analysis of bead-based assays |
11/15/2012 | US20120288717 Functional surface coating |